Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development - PubMed (original) (raw)

Review

Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development

J Bromberg. Breast Cancer Res. 2000.

Abstract

STAT transcription factors were discovered 10 years ago as mediators of interferon-induced gene expression. They now form an important group, comprising seven members, that are activated by virtually every cytokine and growth factor. Their critical role in development and normal cell signaling has been largely determined through the analysis of transgenic mice lacking individual STAT genes. In addition, cell culture work has further delineated their importance in cellular transformation, apoptosis, differentiation and growth control. This review discusses the specific phenotypes of STAT-deficient animals with a focus on STAT5 and STAT3, as these two STAT molecules are required for normal breast development and involution, respectively, and may play an important role in breast carcinogenesis.

PubMed Disclaimer

Similar articles

• Activation of STAT proteins and growth control.
  Bromberg JF. Bromberg JF. Bioessays. 2001 Feb;23(2):161-9. doi: 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0. Bioessays. 2001. PMID: 11169589 Review.
• The role of STATs in transcriptional control and their impact on cellular function.
  Bromberg J, Darnell JE Jr. Bromberg J, et al. Oncogene. 2000 May 15;19(21):2468-73. doi: 10.1038/sj.onc.1203476. Oncogene. 2000. PMID: 10851045 Review.
• Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
  Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F. Spiekermann K, et al. Eur J Haematol. 2001 Aug;67(2):63-71. Eur J Haematol. 2001. PMID: 11722592
• STAT proteins as novel targets for cancer drug discovery.
  Turkson J. Turkson J. Expert Opin Ther Targets. 2004 Oct;8(5):409-22. doi: 10.1517/14728222.8.5.409. Expert Opin Ther Targets. 2004. PMID: 15469392 Review.
• Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development.
  Ebong S, Chepelinsky AB, Robinson ML, Zhao H, Yu CR, Egwuagu CE. Ebong S, et al. Mol Vis. 2004 Feb 19;10:122-31. Mol Vis. 2004. PMID: 14978477

Cited by

• Navigating the Cytokine Seas: Targeting Cytokine Signaling Pathways in Cancer Therapy.
  Stanilov N, Velikova T, Stanilova S. Stanilov N, et al. Int J Mol Sci. 2024 Jan 13;25(2):1009. doi: 10.3390/ijms25021009. Int J Mol Sci. 2024. PMID: 38256080 Free PMC article. Review.
• Reconstruction of the regulatory hypermethylation network controlling hepatocellular carcinoma development during hepatitis C viral infection.
  Antropova EA, Khlebodarova TM, Demenkov PS, Volianskaia AR, Venzel AS, Ivanisenko NV, Gavrilenko AD, Ivanisenko TV, Adamovskaya AV, Revva PM, Kolchanov NA, Lavrik IN, Ivanisenko VA. Antropova EA, et al. J Integr Bioinform. 2023 Nov 20;20(3):20230013. doi: 10.1515/jib-2023-0013. eCollection 2023 Sep 1. J Integr Bioinform. 2023. PMID: 37978846 Free PMC article.
• Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.
  Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, Bao Z, Lu J, Li L. Xue C, et al. Signal Transduct Target Ther. 2023 May 19;8(1):204. doi: 10.1038/s41392-023-01468-7. Signal Transduct Target Ther. 2023. PMID: 37208335 Free PMC article. Review.
• Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.
  Makhlin I, McAndrew NP, Wileyto EP, Clark AS, Holmes R, Bottalico LN, Mesaros C, Blair IA, Jeschke GR, Fox KR, Domchek SM, Matro JM, Bradbury AR, Feldman MD, Hexner EO, Bromberg JF, DeMichele A. Makhlin I, et al. NPJ Breast Cancer. 2022 Nov 11;8(1):122. doi: 10.1038/s41523-022-00487-x. NPJ Breast Cancer. 2022. PMID: 36369506 Free PMC article.
• Unraveling the Role of Guanylate-Binding Proteins (GBPs) in Breast Cancer: A Comprehensive Literature Review and New Data on Prognosis in Breast Cancer Subtypes.
  Hunt EN, Kopacz JP, Vestal DJ. Hunt EN, et al. Cancers (Basel). 2022 Jun 4;14(11):2794. doi: 10.3390/cancers14112794. Cancers (Basel). 2022. PMID: 35681772 Free PMC article.

References

1. 1. Darnell JE., Jr STATs and gene regulation. . Science. 1997;277:1630–1635. - PubMed
2. 1. Stark GR, Kerrr IM, Williams BR, et al. How cells respond to interferons. . Annu Rev Biochem. 1998;67:227–264. - PubMed
3. 1. Chen X, Vinkemeier U, Zhao Y, et al. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. . Cell. 1998;93:827–839. - PubMed
4. 1. Haspel RL, Salditt-Georgieff M, Darnell JE., Jr The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends on a protein tyrosine phosphatase. . EMBO J. 1996;15:6262–6268. - PMC - PubMed
5. 1. Haspel RL, Darnell JE., Jr A nuclear protein tyrosine phosphatase is required for the inactivation of Stat1. . Proc Natl Acad Sci USA. 1999;96:10188–10193. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • BioMed Central
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal